Gastrointestinal tract as major route of pharmaceutical administration

Toxicology of the Gastrointestinal Tract

Volumn , Issue , 2007, Pages 107-133

  Kapp, Robert W ^a  

^a BioTox   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941614341     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (39)

1. Artursson, P. (1991). Cell cultures as models for drug absorption across the intestinal mucosa. Crit. Rev. Therap. Drug Carrier Systems 8: 305-330.
2. Banakar, U.V. and Makoid, M.C. (1997). Pharmacokinetics in Drug Development: Practical Applications. Technomic Publishing Company, Lancaster, PA.
3. Beers, M.H. and Berkow, R., Editors, The Merck Online Manual of Diagnosis and Therapy, 17th ed. http://www.merck.com/
4. Blanchette, J.B., Kavimandan, N., and Peppas, N.A. (2004). Principles of transmucosal delivery of therapeutic agents. Biomed. Pharmacother. 58: 142-151.
5. Bourne, W.A.D. (2001). Pharmacokinetics and Biopharmaceutics, PHAR 7632/7633 & 4634. College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK. http://www.boomer.org/
6. Burton, P.S., Goodwin, J.T. Vidmar, T.J., and Amore, B.M. (2002). Predicting drug absorption:How nature made it a difficult problem. Pharm. Exp. Therap. 303: 889-895.
7. Carlstedt, I., Sheehan, J.K., Corfield, A.P., and Gallagher, J.T. (1985). Mucous glycoproteins:a gel of a problem. Essays Biochem. 20: 40-76.
8. Chiou, W.L. (2001). The rate and extent of oral availability versus the rate and extent of oral absorption: clarification and receommendation of terminology. J. Pharmacokinetics Biopharm. 28: 3-6.
9. Coppoc, G.L. (2004). Biotransformation. Purdue Research Foundation.
10. Coyne, C.B., Vanhook, M.K., Gambling, T.M., Carson, J.L., Boucher, R.C., and Johnson, L.G. (2002). Regulation of airway tight junctions by proinflammatory cytokines. Mol. Biol. Cell 13: 3218-3234.
11. Fallingborg, J., Christensen, L.A., Ingeman-Nielsen, M., Jacobsen, B.A., Abildgaard, K., and Rasmussen, H.H. (1989). Aliment. Pharmacol. Therap. 3: 605-613.
12. Fasano, A. and Shea-Donohue, T. (2005). Mechanisms of disease: role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Gastroenterol. Hepatol. 2: 416-422.
13. Fromm, M. and Hierholzer, K. (2000). Epithelium, in Physiology des Menschen, Vol. 34, Schmidt, R.F. et al., Eds., Springer, Berlin, p. 719.
14. Furuse, M, Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., and Tsukita, S. (1993). Occludin: a novel integral membrane protein localizing at tight junctions J. Cell Biol. 123: 1777-1788.
15. Furuse, M. Fujita, K. Hiiragi, T. Fujimoto, K., and Tsukita, S. (1998). Claudin-1 and -2:novel integral membrane proteins localizing at tight junctions. J. Cell Biol., 141:1539-1550.
16. Galia, E., Nicolaides, E., Horter, D., Lobenberg, R., Reppas, C., and Dressman, J.B. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15: 698-705.
17. Gregus, Z. and Klaassen, C.D. (2001). Mechanisms of toxicity, in Casarett & Doull’s Toxicology: The Basic Science of Poisons, 6th ed., Klaasen, C.D., Ed., McGraw-Hill, New York. pp. 35-81.
18. Harding, S.E. (2003). Mucoadhesive interactions. Biochem. Soc. Trans. 31: 1036-1041.
19. Hoffman, A.F. (1994). Intestinal absorption of bile acids and biliary constituents, in Physiology of the Gastrointestinal Tract, Johnson, L.R., Ed., Raven Press, New York, pp. 1845-1865.
20. Ilett, K.F., Tee, L.B.G., Reeves, P.T., and Minchin, R.F. (1990). Metabolism of drugs and other xenobiotics in the gut lumen wall. Aliment. Pharmacol. Therap. 46: 67-93.
21. Jung, D., Fantin, A.C., Scheurer, U., Fried, M., and Kullak-Ublick, G.A. (2004). Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53: 78-84.
22. Kapp, R.W. (2007). Gastrointestinal toxicology, in Principles and Methods of Toxicology, 5th ed., Taylor & Francis, Philadelphia, chap. 26.
23. Kimball, J.W. (2005). Kimball’s Biology Pages: Online Biology Textbook. http://biologypages. info
24. Kiuchi-Saishin, Y., Gotoh, S., Furuse, M., Rakasuga, A., Tano, Y., and Tsukita, S. (2002). J. Am Soc. Nephrol. 13: 875-886.
25. Kulkarni A., Han Y., and Hopfinger, A.J. (2002). Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis. J. Chem. Inf. Comput. Sci. 42: 331-342.
26. Lin, J.H., Chiba, M., and Baillie, T.A. (1999). Is the role of the small intestine in first pass metabolism overemphasized? Pharmacol. Rev. 51: 135-158.
27. Lipinski, C.A., Lombardo, F., Dominy, B.W., and Feeney, P.J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 23: 3-25.
28. Magee, D.F. and Dalley, A.F. (1986). Digestion and the Structure and Function of the Gut, Vol. 8, Continuing Education Series, Karger, Basel.
29. Martin-Padura, I., Lostaglio, S., Schneemann, M., Williams, L. et al. Junctional adhesion molecule: a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:117-127.
30. Pang, K.S. (2003). Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette review series). Drug Metabol. Dispos. 31:1507-1519.
31. Pond, S.M. and Tozer, T.N. (1985). First-pass elimination: basic concepts and clinical consequences. Clin. Pharmacokinetics 9: 1-25.
32. Renwick, A.G. and George, C.F. (1989). Metabolism of xenobiotics in the gastrointestinal tract, in Xenobiotic Metabolism in Animals: Methodology, Mechanisms and Significance, Huston, D.H. et al., Eds., Taylor & Francis, London, pp. 13-40.
33. Ritter, J., Moore, P., Rang, H.P., and Dale, M.M. (2003). Absorption and distribution of drugs, in Pharmacology, 5th ed., Ritter, J. et al., Eds., Churchill Livingston, London, chap. 7.
34. Rozman, K.K. and Klaassen, C.D. (2001). Adsorption, distribution, and excretion of toxicants, in Casarett & Doull’s Toxicology: The Basic Science of Poisons, 6th ed., Klaassen, C.D., Ed., McGraw-Hill, New York. p. 107-132.
35. Shargel, L. and Yu, A.B. (1999). Applied Biopharmaceutics and Pharmacokinetics, 4th Ed., McGraw-Hill, New York.
36. Watts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not., T., Zielke, R., and Fasano, A. (2005). Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl. Acad. Sci. USA 102: 2916-2921.
37. Whitehead, K. and Mitragotri, S. (2005). Oral Delivery of Macromolecules. Drug Delivery Companies Report, Spring/Summer 2005, PharmaVentures, http://www.drug deliveryreport.com/articles/ddcr_s2005_article2.pdf.
38. Wilson, B. (2004). Fick’s First Law, Connexions Web site: http://cnx.rice.edu/content/m11365/1.2/.
39. Wright, Stephen (2005). Human Physiology 801, University of Arizona, Tucson. http://human.physiol.arizona.edu/.